392 related articles for article (PubMed ID: 28820068)
1. Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer.
Peron G; Marzaro G; Dall Acqua S
Curr Med Chem; 2018; 25(10):1259-1269. PubMed ID: 28820068
[TBL] [Abstract][Full Text] [Related]
2. Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity.
Ren Y; Kinghorn AD
Planta Med; 2019 Aug; 85(11-12):802-814. PubMed ID: 30658371
[TBL] [Abstract][Full Text] [Related]
3. Triterpenoids as new promising anticancer drugs.
Petronelli A; Pannitteri G; Testa U
Anticancer Drugs; 2009 Nov; 20(10):880-92. PubMed ID: 19745720
[TBL] [Abstract][Full Text] [Related]
4. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
[TBL] [Abstract][Full Text] [Related]
5. Triterpene derivatives as inhibitors of protein involved in the inflammatory process: molecules interfering with phospholipase A2, cycloxygenase, and lipoxygenase.
Braca A; Dal Piaz F; Marzocco S; Autore G; Vassallo A; De Tommasi N
Curr Drug Targets; 2011 Mar; 12(3):302-21. PubMed ID: 20955150
[TBL] [Abstract][Full Text] [Related]
6. Bioactive triterpenoids from Callistemon lanceolatus.
Jeong W; Hong SS; Kim N; Yang YT; Shin YS; Lee C; Hwang BY; Lee D
Arch Pharm Res; 2009 Jun; 32(6):845-9. PubMed ID: 19557361
[TBL] [Abstract][Full Text] [Related]
7. Biotransformations of diterpenoids and triterpenoids: a review.
Bhatti HN; Khera RA
J Asian Nat Prod Res; 2014 Jan; 16(1):70-104. PubMed ID: 24266458
[TBL] [Abstract][Full Text] [Related]
8. Recent studies on natural products as anticancer agents.
Ravelo AG; Estévez-Braun A; Chávez-Orellana H; Pérez-Sacau E; Mesa-Siverio D
Curr Top Med Chem; 2004; 4(2):241-65. PubMed ID: 14754457
[TBL] [Abstract][Full Text] [Related]
9. 3-Pyridinylidene Derivatives of Chemically Modified Lupane and Ursane Triterpenes as Promising Anticancer Agents by Targeting Apoptosis.
Kazakova O; Șoica C; Babaev M; Petrova A; Khusnutdinova E; Poptsov A; Macașoi I; Drăghici G; Avram Ș; Vlaia L; Mioc A; Mioc M; Dehelean C; Voicu A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639035
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
11. Triterpenoids from
Sun Y; Gao LL; Tang MY; Feng BM; Pei YH; Yasukawa K
Molecules; 2018 Aug; 23(9):. PubMed ID: 30135395
[No Abstract] [Full Text] [Related]
12. Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities.
Dinh Ngoc T; Moons N; Kim Y; De Borggraeve W; Mashentseva A; Andrei G; Snoeck R; Balzarini J; Dehaen W
Bioorg Med Chem; 2014 Jul; 22(13):3292-300. PubMed ID: 24844757
[TBL] [Abstract][Full Text] [Related]
13. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
14. Enhancing anticancer activity through the combination of bioreducing agents and triterpenes.
Bednarczyk-Cwynar B; Ruszkowski P; Jarosz T; Krukiewicz K
Future Med Chem; 2018 Mar; 10(5):511-525. PubMed ID: 29424550
[TBL] [Abstract][Full Text] [Related]
15. Advances in Chemistry and Pharmacology of Triterpenoid Synthetic Dimers.
Bednarczyk-Cwynar B; Günther A
Curr Med Chem; 2017; 24(20):2205-2240. PubMed ID: 28155603
[TBL] [Abstract][Full Text] [Related]
16. Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.
Gudoityte E; Arandarcikaite O; Mazeikiene I; Bendokas V; Liobikas J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925641
[TBL] [Abstract][Full Text] [Related]
17. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy.
Laszczyk MN
Planta Med; 2009 Dec; 75(15):1549-60. PubMed ID: 19742422
[TBL] [Abstract][Full Text] [Related]
18. Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark.
Mishra T; Arya RK; Meena S; Joshi P; Pal M; Meena B; Upreti DK; Rana TS; Datta D
PLoS One; 2016; 11(7):e0159430. PubMed ID: 27453990
[TBL] [Abstract][Full Text] [Related]
19. Chemical constituents from Inonotus obliquus and their antitumor activities.
Zhao F; Xia G; Chen L; Zhao J; Xie Z; Qiu F; Han G
J Nat Med; 2016 Oct; 70(4):721-30. PubMed ID: 27180084
[TBL] [Abstract][Full Text] [Related]
20. Ursolic Acid and Its Derivatives as Bioactive Agents.
Mlala S; Oyedeji AO; Gondwe M; Oyedeji OO
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
